-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Passage BIO, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2019 to Q3 2024.
- Passage BIO, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$20.7M, a 27.8% increase year-over-year.
- Passage BIO, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$74.6M, a 36.9% increase year-over-year.
- Passage BIO, Inc. annual Operating Income (Loss) for 2023 was -$108M, a 21.7% increase from 2022.
- Passage BIO, Inc. annual Operating Income (Loss) for 2022 was -$138M, a 25.5% increase from 2021.
- Passage BIO, Inc. annual Operating Income (Loss) for 2021 was -$186M, a 64.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)